Lietard et al.
stirring at room temperature, the reaction was quenched with
methanol (2 mL). The mixture was treated with aqueous NaHCO3
(300 mL), and the title compound was extracted with CH2Cl2 (3 ×
150 mL). The organic layer was dried over Na2SO4 and evaporated
under reduced pressure. The oily residue was purified by silica gel
chromatography using an increasing amount of methanol (0-2%)
in CH2Cl2 containing 1% of Et3N affording 14 as a colorless oil:
1.9 g, 56% Rf ) 0.28 (CH2Cl2/MeOH, 19:1, v/v). 1H NMR (CDCl3,
400 MHz): δ 0.87 (3H, s), 2.42 (2H, br s), 3.16 (2H, s), 3.69 (2H,
d, J ) 25.2 Hz) 3.64 (2H, d, J ) 25.2 Hz), 3.82 (6H, s), 6.79-
7.49 (13H, m). 13C NMR (CDCl3, 100 MHz): δ 17.4, 41.1, 55.2,
67.2, 68.2, 86.3, 113.3, 126.9, 128.0, 130.0, 135.8, 144.7, 158.5.
HRFABMS (positive mode, nitrobenzylic alcohol) m/z: calcd for
C26H30O5 [M + H]+ 422.2093, found 422.2098.
42.9, 43.0, 43.1, 55.3, 63.4, 84.8, 86.9, 111.2, 113.3, 127.1, 128.0,
128.2, 130.1, 135.3, 135.4, 135.5, 135.8, 144.4, 150.2, 158.7, 163.7.
31P NMR (CDCl3, 80 MHz): δ 147.8 and 148.3.
1-O-(4,4′-Dimethoxytrityloxymethyl)-2,2-bis-propargyloxym-
ethyl-3-O-(succinic-LCAA CPG)-1,3-propanediol (26). LCAA-
CPG (1.00 g), 1-O-(4,4′-dimethoxytrityl)-2,2-bis-propargyloxymethyl-
1,3-propanediol 847 (0.114 g, 0.2 mmol), EDC (0.191 g, 1 mmol),
DMAP (0.012 g, 0.1 mmol), and Et3N (0.1 mL) were shaken in
anhydrous pyridine (5 mL) at room temperature for 48 h. Then
pentachlorophenol (135 mg, 0.5 mmol) was added, and the mixture
was shaken for 10 h. Piperidine (5 mL) was added, and after 5
min of shaking, the solid support was filtered off, washed with
CH2Cl2, and dried. A capping step with standard Cap A and Cap
B solutions was applied for 2 h, and the solid support was filtered
off, washed with CH2Cl2, and dried. Trityl assay indicated a loading
of 40 µmol/g.
Oligonucleotide Synthesis. Oligonucleotides (1 µmol scale) were
synthesized on an ABI 381A or 394 DNA synthesizer using a cycle
involving phosphoramidite chemistry. Detritylation was performed
with 2.5% DCA in CH2Cl2 for 60 s. Coupling step: BMT (0.3 M
in dry acetonitrile) was used as activator; propynyl and bromohexyl
phosphoramidites (0.09 M in CH3CN) were introduced with a 45
s coupling time; commercially available phosphoramidites (0.09M
in CH3CN) were introduced with a 30 s coupling time. The capping
step was performed with acetic anhydride using commercial solution
(Cap A: Ac2O, pyridine, THF 10/10/80 and Cap B: 10%
N-methylimidazole in THF) for 15 s. Oxidation was performed with
commercial solution of iodide (0.1 M I2, THF, pyridine/water 90/
5/5) for 10 s.
1-Propargyl-2-[(4,4′-dimethoxytrityl)oxymethyl]-2-methylpro-
pane-1,3-diol (15). Compound 14 (620 mg, 1.47 mmol) was
dissolved in anhydrous THF (6 mL), and sodium hydride (60% in
oil, 590 mg, 14.7 mmol) was added. After 10 min of stirring,
propargyl bromide (80% in toluene, 650 mL, 5.9 mmol) was added,
and the mixture was stirred at rt for 1 h. Then CH2Cl2 (100 mL)
and 2 mL of water were added. The organic layer was washed with
water (2 × 100 mL) and dried over Na2SO4. After evaporation,
the residue was purified by flash chromatography using an
increasing amount of ethyl acetate (10% to 50%) in cyclohexane
1
containing 1% of triethylamine: 500 mg 74%. H NMR (CDCl3,
200 MHz): δ 0.95 (3H, s), 2.58 (1H, t), 2.60 (1H, br s), 3.03 (1H,
d, J ) 20.7 Hz) 3.13 (1H, d, J ) 20.7 Hz) 3.58-3.6 (2H, m), 3.65
(2H, s), 3.82 (6H, s), 4.18 (2H, dd, J ) 0.9 and 1.4 Hz), 6.85-
7.54 (13H, m). 13C NMR (CDCl3, 100 MHz): δ 17.8, 40.8, 55.2,
58.7, 66.5, 68.9, 74.3, 74.5, 79.7, 86.0, 113.2, 126.7, 127.8, 128.1,
129.1, 130.1, 136.0, 145.0, 158.4. HRFABMS (positive mode,
nitrobenzylic alcohol) m/z: calcd for C29H32O5 [M + H]+ 460.2250,
found 460.2248.
General Procedure for Azidation. Azidation of 5′-hydroxyl
oligonucleotides was performed according to the procedure de-
scribed by Kool et al.38
1-Propargyl-2-[(4,4′-dimethoxytrityl)oxymethyl]-2-methyl-3-
(succinic-LCAA CPG)-propane-1,3-diol (16). Same protocol as
for 11. Loading 32.2 µmol/g for LCAA CPG 500 Å and 30.1
µmol/g for LCAA CPG 1000 Å.
Azidation from bromohexyl oligonucleotides was performed as
follows: A solution of NaN3 (13 mg) and NaI (30 mg) in dry DMF
(1.5 mL) was applied on the solid-supported bromohexyl oligo-
nucleotide for 1 h 15 min at 65 °C. Then the CPG beads bearing
the oligonucleotide were washed with DMF (2 × 1 mL) and CH2-
Cl2 (5 mL) and dried in a desiccator under reduced pressure for 30
min.
General Procedure for Deprotection. The beads were placed
into a sealed vial and treated with concentrated aqueous ammonia
(1 mL) for 24 h at room temperature for oligonucleotides containing
phosphotriester functions or 2 h at room temperature and then 5 h
at 55 °C for the others. The beads were filtered off, and the solution
was evaporated. The residue was dissolved in water for subsequent
analyses.
General Procedure for Cu(I)-Catalyzed 1,3-Dipolar Cycload-
dition. To azido-alkyne oligonucleotide (∼1 µmol) were added
CuSO4 (0.4 equiv, 0.4 µmol, 13.2 µL of a 20 mM solution in H2O),
freshly prepared (from degassed water) sodium ascorbate (2 equiv,
2 µmol, 13.2 µL of a 100 mM solution in H2O), methanol (100
µL), and water (23.6 µL). The tube containing the resulting
preparation was flushed with argon and sealed. The reaction was
placed in a microwave synthesizer Initiator from Biotage set at 100
W with a 30 s premixing time for 1 to 1 h 30 min at 60 °C.
Temperature was monitored with an internal infrared probe. The
solution was then desalted on NAP10.
6-Bromohexyl 2-cyanoethyl diisopropylphosphoramidite (17).
To a solution of anhydrous 6-bromo-1-hexanol (325 mg, 1.8 mmol)
and diisopropylammonium tetrazolide (154 mg, 0.9 mmol) in
anhydrous dichloromethane (5 mL) was added 2-cyanoethyl tet-
raisopropylphosphorodiamidite (570 µL, 1.8 mmol). The resulting
mixture was stirred for 5 h at room temperature, diluted with ethyl
acetate (30 mL), and washed with brine (2 × 100 mL). The organic
layer was dried (Na2SO4), filtered, and evaporated to dryness. The
residue was purified by flash column chromatography (silica gel;
cyclohexane with 3% Et3N) affording phosphoramidite 1 (400 mg
60% yield) as a colorless oil. TLC (cyclohexane/CH2Cl2/Et3N; 5/4/
1; v/v/v) Rf: 0.5. 1H NMR (CDCl3, 200 MHz): δ 1.17-1.21 (12H,
d), 1.44-1.88 (8H, m), 2.62-2.69 (2H, m), 3.39-3.87 (8H, m).
13C NMR (CDCl3, 100 MHz): δ 19.9, 24.0, 24.1, 24.2, 24.7, 27.3,
29.7, 30.4, 30.5, 32.2, 33.3, 42.4, 42.6, 57.7, 57.9, 62.9, 63.1, 117.1
31P NMR (CDCl3,80 MHz): δ 148.5 ppm.
6-Bromo-1-hexyl Tetraisopropylphosphorodiamidite (23). Us-
ing the same protocol as for 1 starting from 6-bromo-1-hexanol
1
271.6 mg 1.5 mmol gave 410 mg (90%). H NMR (CDCl3, 200
MHz): δ 1.16-1.20 (24H, dd), 1.42-1.47 (4H, m), 1.56-1.65
(2H, m), 1.85-1.92 (2H, m), 3.39-3.62 (8H, m). 13C NMR (CDCl3,
100 MHz): δ 23.6, 23.7, 24.6, 24.7, 27.9, 31.4, 31.5, 32.8, 33.7,
44.1, 44.4, 63.9, 64.1, 31P NMR (CDCl3,80 MHz): δ 125.3 ppm.
5′-O-Dimethoxytrityl-3′-O-[(6-bromohexyl)-N,N-diisopropy-
lphosphoramidite]thymidine (24). Using the same protocol as for
2 starting from 5′-dimethoxytritylthymidine (300 mg, 0.54 mmol)
and using 6-bromo-1-hexytetraisopropylphosphorodiamidite (23)
afforded 377 mg 82% of 24. 1H NMR (CDCl3, 200 MHz): δ 1.4-
1.20 (12H, m), 1.36-1.88 (9H, m), 2.50-2.65 (2H, m), 3.35-3.7
(8H, m), 3.81 (6H, s), 4.17-4.22 (1H, m), 4.61-4.69 (1H, m),
6.40-6.46 (1H, m), 6.83-7.67 (14H, m). 13C NMR (CDCl3, 100
MHz): 11.7, 24.5, 24.6, 25.1, 25.2, 27.8, 31.0, 32.7, 33.8, 339,
Acknowledgment. We thank the Universite´ Montpellier 2,
CNRS, and Inserm for financial supports.
Supporting Information Available: HPLC profiles and MALDI-
1
TOF MS spectra of oligonucleotides synthesized. H NMR, 13C
NMR, and 31P NMR spectra of all new compounds. This material
JO702177C
200 J. Org. Chem., Vol. 73, No. 1, 2008